发明名称 ASPIRIN FORMULATION FOR INCREASED EFFICACY
摘要 Provided are methods for enhancing the efficacy of aspirin. Also provided are methods for reducing pain or preventing or treating heart attack, stroke or blood clot in a subject in need thereof. The methods entail orally administering to the subject a first composition comprising a first amount of aspirin, and a second composition comprising a second amount of aspirin, wherein the first composition is formulated so as to, upon administration, disintegrate or dissolve intraorally providing rapid release of the aspirin of the first composition in the subject, and wherein the second composition is formulated to be substantially more difficult than the first composition to disintegrate or dissolve intraorally but is ingestible and releasable in the gastrointestinal track of the subject. The method can further include administering to the subject a painkiller or an agent suitable for treating a cardiovascular disease or condition.
申请公布号 US2015072005(A1) 申请公布日期 2015.03.12
申请号 US201314023188 申请日期 2013.09.10
申请人 Vitalis LLC 发明人 Habboushe Joseph P.
分类号 A61K31/616;A61K31/522;A61K45/06 主分类号 A61K31/616
代理机构 代理人
主权项 1. A method of increasing aspirin efficacy or reducing aspirin side effects in a subject in need thereof, comprising orally administering, to the subject a first composition comprising a first amount of aspirin, and a second composition comprising a second amount of aspirin, wherein the first composition is formulated so as to, upon administration, disintegrate or dissolve intraorally providing rapid release of the aspirin of the first composition in the subject, and wherein the second composition is formulated to be substantially more difficult than the first composition to disintegrate or dissolve imraorally but is ingestible and releasable in the gastrointestinal track of the subject, and wherein the first amount of aspirin comprises at least about 20% of the sum of the first amount and second amount.
地址 Wilmington DE US